89 related articles for article (PubMed ID: 17617559)
1. Comment on "Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells".
Ghebeh H; Dermime S
J Immunol; 2007 Jul; 179(2):732; author reply 733. PubMed ID: 17617559
[No Abstract] [Full Text] [Related]
2. Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells.
Nazareth MR; Broderick L; Simpson-Abelson MR; Kelleher RJ; Yokota SJ; Bankert RB
J Immunol; 2007 May; 178(9):5552-62. PubMed ID: 17442937
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors.
Barnas JL; Simpson-Abelson MR; Brooks SP; Kelleher RJ; Bankert RB
J Immunol; 2010 Sep; 185(5):2681-92. PubMed ID: 20686130
[TBL] [Abstract][Full Text] [Related]
4. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.
Konishi J; Yamazaki K; Azuma M; Kinoshita I; Dosaka-Akita H; Nishimura M
Clin Cancer Res; 2004 Aug; 10(15):5094-100. PubMed ID: 15297412
[TBL] [Abstract][Full Text] [Related]
5. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
[TBL] [Abstract][Full Text] [Related]
6. Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3.
Schneider T; Hoffmann H; Dienemann H; Schnabel PA; Enk AH; Ring S; Mahnke K
J Thorac Oncol; 2011 Jul; 6(7):1162-8. PubMed ID: 21597388
[TBL] [Abstract][Full Text] [Related]
7. Increase of programmed death ligand 1 in non-small-cell lung cancers with chronic hepatitis B.
Lin G; Zhuang W; Chen XH; Huang C; Lin XD; Huang YJ; Li C
Ann Oncol; 2018 Feb; 29(2):516-517. PubMed ID: 29088325
[No Abstract] [Full Text] [Related]
8. Functional immune characterization of HIV-associated non-small-cell lung cancer.
Pinato DJ; Kythreotou A; Mauri FA; Suardi E; Allara E; Shiner RJ; Akarca AU; Trivedi P; Gupta N; Dalla Pria A; Marafioti T; Oliveri P; Newsom-Davis T; Bower M
Ann Oncol; 2018 Jun; 29(6):1486-1488. PubMed ID: 29897389
[No Abstract] [Full Text] [Related]
9. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
[TBL] [Abstract][Full Text] [Related]
10. CD4+CXCR4highCD69+ T cells accumulate in lung adenocarcinoma.
Wald O; Izhar U; Amir G; Avniel S; Bar-Shavit Y; Wald H; Weiss ID; Galun E; Peled A
J Immunol; 2006 Nov; 177(10):6983-90. PubMed ID: 17082613
[TBL] [Abstract][Full Text] [Related]
11. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation.
Zhang J; Cao D; Yu S; Chen L; Wei D; Shen C; Zhuang L; Wang Q; Xu X; Tong Y
BMC Cancer; 2018 Apr; 18(1):467. PubMed ID: 29695237
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung Cancer.
de Goeje PL; Smit EF; Waasdorp C; Schram MTB; Kaijen-Lambers MEH; Bezemer K; de Mol M; Hartemink KJ; Nuyttens JJME; Maat APWM; Hegmans JPJJ; Hendriks RW; Senan S; Aerts JGJV
Am J Respir Crit Care Med; 2017 Nov; 196(9):1224-1227. PubMed ID: 28345951
[No Abstract] [Full Text] [Related]
15. Ubiquitinated Proteins Isolated From Tumor Cells Are Efficient Substrates for Antigen Cross-Presentation.
Yu G; Moudgil T; Cui Z; Mou Y; Wang L; Fox BA; Hu HM
J Immunother; 2017 Jun; 40(5):155-163. PubMed ID: 28368960
[TBL] [Abstract][Full Text] [Related]
16. Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice.
Simpson-Abelson MR; Sonnenberg GF; Takita H; Yokota SJ; Conway TF; Kelleher RJ; Shultz LD; Barcos M; Bankert RB
J Immunol; 2008 May; 180(10):7009-18. PubMed ID: 18453623
[TBL] [Abstract][Full Text] [Related]
17. Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.
Paulsen EE; Kilvaer TK; Khanehkenari MR; Al-Saad S; Hald SM; Andersen S; Richardsen E; Ness N; Busund LT; Bremnes RM; Donnem T
Clin Lung Cancer; 2017 Mar; 18(2):220-233.e8. PubMed ID: 27816392
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of peripheral blood T lymphocyte surface activation markers and transcription factors in patients with early stage non-small cell lung cancer.
Rutkowski J; Cyman M; Ślebioda T; Bemben K; Rutkowska A; Gruchała M; Kmieć Z; Pliszka A; Zaucha R
Cell Immunol; 2017 Dec; 322():26-33. PubMed ID: 28939130
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.
Franciszkiewicz K; Le Floc'h A; Jalil A; Vigant F; Robert T; Vergnon I; Mackiewicz A; Benihoud K; Validire P; Chouaib S; Combadière C; Mami-Chouaib F
Cancer Res; 2009 Aug; 69(15):6249-55. PubMed ID: 19638592
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.
Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R
Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
